Standing Order
Lantheus Holdings, Inc.

Dashboard

Lantheus Holdings, Inc.

LNTHNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$6.5B
Price$99.9752w $50.11 – $110.94
Conviction4/ 5
Revenue (TTM)$1.6B
Revenue growth YoY+2.3%
P/E (trailing)23.7
Gross margin60.1%
Operating margin19.4%
Net margin17.7%
52w price change+29.6%
Next earningsNov 5, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Sep 21
    OtherSEC

    8-K filed under item 8.01 (other events).

  • Sep 8
    M&ASEC

    Filed DEFM14A definitive proxy statement for merger or acquisition.

  • Sep 8
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities by an insider.

  • Sep 4
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • Sep 3
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Sep 2
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • Sep 2
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Aug 26
    M&ASEC

    PREM14A preliminary proxy statement filed for merger or acquisition.

  • Aug 19
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Aug 19
    Ownership changeSEC

    Form 4 filing: statement of changes in beneficial ownership of securities.

  • Aug 6
    Financial resultsSEC

    Lantheus Holdings files 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.

  • Aug 4
    LeadershipSEC

    8-K reports entry into material definitive agreement (item 1.01) and officer/director changes (item 5.02).

  • Aug 3
    OtherSEC

    Lantheus Holdings files 8-K covering items 7.01 (Reg FD), 8.01 (other events), and 9.01 (exhibits).

  • Jul 22
    RegulatoryFDA

    FDA supplemental submission (SUPPL-41) action for NEURACEQ under NDA204677.

  • Jun 3
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • Jun 3
    Ownership changeSEC

    Form 4 filing: change in beneficial ownership reported

  • May 18
    OtherSEC

    SEC Form 4 filed reporting changes in beneficial ownership of securities.

  • May 18
    OtherSEC

    Form 4 filing reporting change in beneficial ownership of securities.

  • May 18
    OtherSEC

    SEC Form 4 filed reporting change in beneficial ownership of securities.

  • May 18
    OtherSEC

    Form 4 filing reporting change in beneficial ownership of securities.

Not financial advice — research and opinion only. Disclosures